MANNKIND CORP

MNKD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $-117.3M $125.7M $-368.4M $-198.4M $-191.5M $-169.4M $-160.8M $-170.6M
Depreciation & Amortization $1.8M $2.4M $11.0M $9.8M $11.5M $13.0M $14.6M $16.5M
Depreciation $1.8M $2.4M
Amortization
Stock-Based Compensation $4.8M $5.1M $8.7M $48.6M $45.2M $13.3M $11.2M $13.6M
Net Cash from Operating Activities $-64.8M $-78.1M $-57.2M $4.1M $-128.7M $-119.9M $-123.8M $-148.7M
Investing Activities
Capital Expenditures $1.1M $10.3M $24.1M $8.0M $637.0K $6.9M $9.5M
Business Acquisitions
Net Cash from Investing Activities $16.7M $-1.1M $-8.0M $-560.0K $-2.9M $-11.7M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $73.6M $43.0M $145.7M $179.6M $63.4M $196.4M
Net Change in Cash $25.5M $-36.2M $-61.8M $50.1M $9.0M $59.2M $-63.4M $36.0M
Free Cash Flow $-79.2M $-67.5M $-20.0M $-136.7M $-120.5M $-130.7M $-158.2M
← Newer Page 2 of 5 Older →